Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice (Q40958594)

25 September 2017

title

Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice (English)

1 reference

25 September 2017

0 references

1 reference

S Frank

1

1 reference

25 September 2017

A Hrzenjak

2

1 reference

25 September 2017

K Kostner

3

1 reference

25 September 2017

W Sattler

4

1 reference

25 September 2017

G M Kostner

5

1 reference

25 September 2017

publication date

1 April 1999

1 reference

Biochimica et Biophysica Acta

25 September 2017

published in

1 reference

25 September 2017

volume

1438

1 reference

25 September 2017

issue

1

1 reference

25 September 2017

page(s)

99-110

1 reference

Lipoprotein (a). Heterogeneity and biological relevance

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Lipoprotein Lp(a) and the risk for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Turnover of lipoprotein (a) in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Molecular definition of the extreme size polymorphism in apolipoprotein(a).

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Comparison of ligand-binding sites of modeled apo[a] kringle-like sequences in human lipoprotein[a]

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Cys4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": the role of kringle IV sequences in the extracellular association with low-density lipoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Structural requirements of apo-a for the lipoprotein-a assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Inhibitors for the In Vitro Assembly of Lp(a)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

The role of apo-(a) kringle-IVs in the assembly of lipoprotein-(a)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

A two-step model for lipoprotein(a) formation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Analysis of the mechanism of lipoprotein(a) assembly

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Site-specific Mutagenesis Demonstrates That Cysteine 4326 of Apolipoprotein B Is Required for Covalent Linkage with Apolipoprotein(a) in Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Expression of a recombinant apolipoprotein(a) in HepG2 cells. Evidence for intracellular assembly of lipoprotein(a).

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

The role of lecithin: cholesterol acyltransferase for lipoprotein (a) assembly. Structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Carboxyl-terminal truncation of apolipoproteinB-100 inhibits lipoprotein(a) particle formation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Quantitation, isolation, and characterization of human lipoprotein (a)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Dietary and genetic interactions in the regulation of plasma lipoprotein(a).

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Interaction of Lp(a) and of apo(a) with liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Demonstration of covalent binding of lipoprotein(a) [Lp(a)] to fibrin and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

Lipoprotein(a) vascular accumulation in mice. In vivo analysis of the role of lysine binding sites using recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS1388-1981%2899%2900044-X

7 January 2021

10.1016/S1388-1981(99)00044-X

Identifiers

DOI

1 reference

release_ecskwzsadjb4hmo4zgrk6jyyv4

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ecskwzsadjb4hmo4zgrk6jyyv4

24 November 2022

mapped directly with Wikidata item

1 reference